The FDA is weighing the first-ever request to make a birth control pill available without a prescription. An advisory panel will meet next week to vote on whether it should be approved for over-the-counter use.
, which is not a contraceptive. Research for over-the-counter use began nearly a decade ago.
FDA’s decision won’t apply to other birth control pills, only Opill, although advocates hope that an approval decision might push other pill makers to seek over-the-counter sales. Birth control pills are available without a prescription across much of South America, Asia and Africa. Women were paid to track and record their use of the pill, including whether they followed instructions to take it during the same 3-hour window each day. That consistency is key to the drug’s ability to block pregnancy.
The most popular birth control pills today contain the synthetic hormone progestin, which helps block pregnancy, plus estrogen. The addition of estrogen can help make periods lighter and more regular but it also carries the risk of rare blood clots.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA weighing 1st over-the-counter birth control pillU.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription
Baca lebih lajut »
FDA weighing 1st over-the-counter birth control pillThe FDA panel will vote on whether the benefits of making the pill more widely available outweigh the potential risks.
Baca lebih lajut »
1st RSV vaccine for older adults in US cleared by FDA in historic approvalThe U.S. Food and Drug Administration has approved the first RSV vaccine in the U.S.
Baca lebih lajut »
In historic approval, FDA clears 1st RSV vaccine for older adults in USThe U.S. Food and Drug Administration has approved the first RSV vaccine in the U.S.
Baca lebih lajut »
After decades of attempts, FDA approves 1st vaccine for RSVAfter decades of scientific research, the first vaccine for respiratory syncytial virus (RSV), designed to protect older adults, has been approved by the United States.
Baca lebih lajut »
1st vaccine for RSV approved by FDAThe U.S. has approved the first vaccine for RSV, shots to protect older adults.
Baca lebih lajut »